SUPPORT FINAL TEST 2026 QUESTIONS
WITH CORRECT ANSWERS GRADED A+
◍ Describe drug therapy/interventions during tachycardia with a pulse
(unstable):.
Answer: 1. Synchronized cardioversion: refer to your specific device's
recommended energy level to maximize first shock success.2. Adenosine:
first dose (6 MG RAPID IV PUSH); follow with rapid normal saline flush.
Second dose (12 MG IF REQUIRED).
◍ What is the difference between ACLS/BLS.
Answer: 1. More equipment to supportventilation and oxygenation.2. ECG
3. Establishing vascular access route for drugs4. Applying selected
pharmacologic agents and electrical therapies
◍ What rhythms can you cardiovert?.
Answer: V tach with a pulse, A Fib, SVT
◍ If in V Fib you betta.
Answer: D Fib
◍ Second Degree= type 2.
Answer: P wave drops off randomly
◍ What are some BVM contraindications?.
Answer: 1. Gastric Insufflation2. Hyperventilation3. Hypoventilation
◍ Algorithm.
Answer: a way to treat a broad range of patients on the basics of rhythms
◍ Unsynchronized shock is used to treat _______ and _________..
Answer: Vfib; Pulseless VT
, ◍ transcutaneous pacing.
Answer: a device that can pace the heart by delivering an electrical stimulus
through electrodes
◍ T/F: Goal is to restore spontaneous circulation and oxygenation within the
body..
Answer: True
◍ No respiratory distress.
Answer: 2 L per cannula
◍ When do you not use an oropharyngeal airway?.
Answer: When the patient is gagging?
◍ What happens during the initial stabilization phase (post cardiac arrest)?.
Answer: -Resuscitation is ongoing during post-ROSC phase, activities occur
concurrently (prioritization):1. Airway Management: waveform
capnography or capnometry to confirm/monitor ET-Tube placement.2.
Manage Respiratory Parameters: titrate FIO2 for SPO2 92%-98%; 10
breaths/min; PaCO2 35-45 mmHg.3. Manage Hemodynamic Parameters:
crystalloid and/or vasopressor or inotrope (SBP >90 mmHg, MAP >65
mmHg).
◍ Unsynchronized shock, shocks as.
Answer: soon as the button is pushed which is D fibrillation
◍ Describe hypertension management in acute ischemic strokes (Part II):.
Answer: -Management of BP during and after alteplase or other emergency
reperfusion therapy to maintain BP <180/105: monitor BP q15 minutes for 2
hrs from the start of alteplase therapy, then q30 minutes for 6 hrs, then q1
hour for 16 hrs.If systolic BP >180-230 or diastolic BP
>105-120:-LABETALOL 10 mg IV followed by continuous IV infusion 2-8
mg/min; or-NICARDIPINE 5 mg/h IV, titrate up to the desired effect by 2.5
mg/h q5-15 minutes, maximum 15 mg/h; or-CLEVIDIPINE 1-2 mg/h IV,
titrate by doubling the dose q2-5 minutes until desired BP reached,
maximum 21 mg/hIf BP not controlled or diastolic BP >140, consider IV